AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
J. Clin. Oncol 2020 May 28;[EPub Ahead of Print], YK Chae, F Hong, C Vaklavas, HH Cheng, P Hammerman, EP Mitchell, JA Zwiebel, SP Ivy, RJ Gray, S Li, LM McShane, LV Rubinstein, D Patton, PM Williams, SR Hamilton, A Mansfield, BA Conley, CL Arteaga, LN Harris, PJ O'Dwyer, AP Chen, KT FlahertyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.